Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 6, 2025
Nitric Boost Ultra Reviews And Complaints (INVESTIGATED) What You Need to Know Before Buying This Male Performance Booster!
GlobeNewswire
·
May 6, 2025
ALBANY, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Let’s be honest—most guys have seen those supplements that promise the world: more energy, better circulation, improved stamina, and a stronger bedroom performance. They all start to sound the same after a …
Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
GlobeNewswire
·
May 6, 2025
ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk …
Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
GlobeNewswire
·
May 6, 2025
PRINCETON, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …
The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience
GlobeNewswire
·
May 6, 2025
- Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures- - Franchise operations leader Eric Wyatt with …
Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004
GlobeNewswire
·
May 6, 2025
-- PAS-004 shows up to 91% inhibition of pERK, confirming substantial target engagement -- -- One patient in cohort 4A with stage 4 KRAS G12R mutated pancreatic cancer achieves over 5 months of stable disease with tumor volume reduction of -9.8% -- MIAMI, …
MADD Canada’s Campaign 911 Urges People to Report Suspected Impaired Drivers, Riders and Boaters
GlobeNewswire
·
May 6, 2025
OAKVILLE, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- An impaired driver is an emergency. That’s the powerful message at the heart of MADD Canada’s Campaign 911, the national awareness program launching today to encourage Canadians to call 911 and report …
La Campagne 911 de MADD Canada exhorte les gens à signaler les conducteurs d’auto, de VTT et de bateau dont les capacités semblent affaiblies
GlobeNewswire
·
May 6, 2025
OAKVILLE, Ontario, 06 mai 2025 (GLOBE NEWSWIRE) -- Les conducteurs aux capacités affaiblies sont des situations d’urgence. C’est le puissant message au cœur de la Campagne 911 de MADD Canada, le programme de sensibilisation nationale, lancé aujourd’hui …
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
GlobeNewswire
·
May 6, 2025
BURLINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it …
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
GlobeNewswire
·
May 6, 2025
PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New …
TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 6, 2025
Updates from the PLEXI-T™ solid tumor and ALLOHA™ heme Phase 1 clinical trials anticipated by end of year On-track to file IND application for TSC-102-A0301 (CD45; HLA-A*03:01) to FDA in the second half of the year Appointed commercial leader Stephen …
Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care
GlobeNewswire
·
May 6, 2025
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. …
Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes
GlobeNewswire
·
May 6, 2025
Sharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders to approximately $500,000 for the quarter NEW YORK …
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
GlobeNewswire
·
May 6, 2025
Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a …
Mind Lab PRO Under Review: Is Mind Lab Pro® v4.0 Universal Nootropic Brain Booster Safe? Best Nootropics Supplement
GlobeNewswire
·
May 6, 2025
Royal Leamington Spa, May 06, 2025 (GLOBE NEWSWIRE) -- Mind Lab Pro is a nootropic pill containing relatively high concentrations of eleven distinct nootropic substances. It promises to help the following: Focus Energy Mood’s Calmness Memory Clarity …
Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera
GlobeNewswire
·
May 6, 2025
MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare haematologic cancer, for …
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
GlobeNewswire
·
May 6, 2025
Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Duncan Ferguson as Vice President, …
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
GlobeNewswire
·
May 6, 2025
Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis, France and Dublin, Ireland – 6th May 2025– Priothera Ltd., a late-stage biopharma company pioneering the development of …
New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease
GlobeNewswire
·
May 6, 2025
MOUNTAIN VIEW, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced two-year data from FISH…
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
GlobeNewswire
·
May 6, 2025
Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the corporate venture firm of Angelini …
TestoPrime Review and Results: A 30 Day Test By WhatBest Reveals Results Of Using TestoPrime For 1 Month.
GlobeNewswire
·
May 6, 2025
New York, May 06, 2025 (GLOBE NEWSWIRE) -- WhatBest, a leading product review and comparison platform, has published a detailed 30-day user review of TestoPrime, a natural testosterone support supplement gaining traction among men looking to boost energy, …